- Display 15 Products per page
Published: May 30, 2019 | Price: $5,500.00 – $11,000.00
Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. This report, The World Liquid Biopsy Market, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid...Published: May 23, 2019 | Price: $5,500.00 – $11,000.00
Remote Patient Monitoring and Telehealth Market represents Kalorama Information’s 11th edition of coverage of the advanced remote patient monitoring market, reflecting the market’s increasing focus on telehealth and telemedicine. The global patient monitoring and telehealth market has continued its expansion in both the institutional and home segments of the health market, with the United States and many European countries at the forefront of implementation. Telehealth is becoming an integrated part of how health is delivered worldwide. The market has benefited...Published: May 16, 2019 | Price: $8,400.00 – $16,800.00
Comprehensive coverage of the IVD Market including the Worldwide Market Report (11th edition) and the 2019 IVD Market Trends Summary Bundle and save 20% over buying these reports individually! The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition This Kalorama Information report represents the 11th edition of this comprehensive look at the IVD industry. At 1,800 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market. It also profiles...Published: May 8, 2019 | Price: $3,000.00 – $6,000.00
Biopharmaceuticals are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies, and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed to provide a snapshot of issues and trends that are affecting the biosimilar market...Published: April 30, 2019 | Price: $5,500.00 – $11,000.00
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential as discussed in Kalorama’s Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other. The World Infectious Disease Testing Market...Published: April 26, 2019 | Price: $4,500.00 – $9,000.00
Sexually transmitted diseases (STDs) are a major public health issue. There occur approximately 550 million new STDs annually worldwide. In the US, there are more than 35 million each year. Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics) analyzes the current and potential world market from 2018 to 2023 for tests and systems used to diagnose STDs. The key STDs and diagnostics covered in the report are the following: Chlamydia Gonorrhea Syphilis Human Papillomavirus (HPV) Human immunodeficiency viruses (HIV) Herpes simplex...Published: April 26, 2019 | Price: $3,000.00 – $6,000.00
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories, while others mature. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. IVD Market Trends Summary features current trends and updates in the worldwide IVD market. Highlights of these updates include: Market developments in developing markets – Latin America, the Middle East and Eastern Europe Effects of PAMA in...Published: April 23, 2019 | Price: $5,000.00 – $10,000.00
EMR 2019 represents the twelfth time that Kalorama Information has created a detailed study of the electronic medical records (EMR) industry. The report looks at the market and trends affecting electronic medical record software and related services. Included in the report are statistics influencing the industry, demographics, life expectancy, and company strategies. This 450-page report is a complete global analysis of the EMR / EHR market. A market summary includes a total market analysis, including: EMR Market Analysis 2018-2023 ($...Published: April 16, 2019 | Price: $5,000.00 – $10,000.00
Kalorama Information has watched the cancer treatment market evolve over the past two decades and evaluated the impact new technologies are making on the market. The 2019 Worldwide Market for Targeted Cancer Therapeutics focuses on the expanding area of targeted therapies and includes current products available and discusses some of the most exciting developments in progress. This report covers targeted cancer therapies that do at least one of the following: Block or turn off chemical signals that tell the cancer...Published: April 2, 2019 | Price: $4,000.00 – $8,000.00
A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type, by...Published: March 27, 2019 | Price: $5,000.00 – $10,000.00
Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and, most recently, convenience clinics. Kalorama’s Worldwide Market...Published: March 8, 2019 | Price: $5,000.00 – $10,000.00
Clinical laboratories are an essential part of the health industry. It is estimated that between 70% - 80% of physicians’ diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. Clinical Laboratory Services Market provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence...Published: February 26, 2019 | Price:
Published: February 22, 2019 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Molecular diagnostics performed at the point of care or near the patient is regarded as a leading expansion segment in the global in vitro diagnostics (IVD) market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the...Published: February 6, 2019 | Price: $5,000.00 – $10,000.00
The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living This Kalorama Information report, The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living provides detailed market research on the U.S. long-term care market. This market complex and diverse industry evolves nearly every year, and influences other markets such as the sales of pharmaceuticals, devices and healthcare services. For seven editions, Kalorama has provided a look at who is leading, what the...